Intravenous drug use (IDU) poses severe health risks due to direct exposure to harmful substances and unhygienic practices. Common complications include infections like HIV, hepatitis B and C, and bacterial endocarditis. Non-sterile needles increase the risk of abscesses and vein damage. Long-term IDU often leads to systemic health issues, including cardiovascular and pulmonary complications. Harm reduction strategies, such as needle exchange programs and supervised injection sites, aim to mitigate these risks. Coupled with addiction treatment, these interventions improve health outcomes and reduce the societal burden of IDU-related complications.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Trauma: Till death do us part
John Michael Weber, Trauma Healed Life Coach, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GTI, United States
Title : Beating the blues today
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Reduction of chronic neuropathic pain by a THC-CBD combination capsule: ongoing pilot study
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States